Type II diabetic nephropathy in perspective.
The magnitude of type II diabetic nephropathy dilemma is observable in the growing number of diabetic patients with end-stage renal lesion receiving various modalities of treatment. Progressive glomerulopathy associated with proteinuria and hypertension is strongly causative of renal failure and mortality in diabetic patients. Besides hypertension, diabetes exceeds all other glomerulopathies in causing end-stage renal failure. Alterations in glomerular structure and function observed in diabetic patients are implicated in the development and progression of renal derangement. Diabetic glomerulosclerosis, an aggregate of structural and functional perturbations of the kidney, is indicated by alterations in the accumulation of extracellular matrix components, The pathology, epidemiology, risk factors, and other dependent variables may throw some light in the pathogenetic mechanisms and the prevention, treatment, and management modalities of type II diabetic nephropathy.
Chukwuma
C
C
Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki, Finland.
D001786:Blood Glucose / Q000378:metabolism; D001794:Blood Pressure; D003924:Diabetes Mellitus, Type 2 / Q000503:physiopathology* / Q000628:therapy*; D003928:Diabetic Nephropathies / Q000453:epidemiology / Q000503:physiopathology* / Q000628:therapy*; D018450:Disease Progression; D005919:Glomerular Filtration Rate; D006801:Humans; D006973:Hypertension / Q000401:mortality / Q000503:physiopathology; D007676:Kidney Failure, Chronic / Q000453:epidemiology / Q000401:mortality / Q000517:prevention & control; D012307:Risk Factors; D014481:United States / Q000453:epidemiology
D001786:Blood Glucose